Résumés
Résumé
Les télomères sont des structures spécialisées qui protègent les extrémités des chromosomes chez les eucaryotes. L’existence de ces structures a été démontrée il y a soixante ans déjà par des études classiques de cytogénétique. Un nouvel essor dans la recherche sur les télomères a eu lieu dans les années 1980, grâce à l’élucidation de la nature moléculaire des télomères. La découverte et la caractérisation de l’enzyme télomérase, une nouvelle ADN polymérase, en sera le principal fer de lance. Actuellement, une des nouvelles fonctions attribuées aux télomères est leur implication, comme horloge biologique, dans le vieillissement des cellules. De plus, la longueur des télomères et la télomérase jouent un rôle dans des phénomènes biologiques aussi variés que le vieillissement des organismes, mais aussi la reproduction, le cancer ou les réponses immunes contre une infection. Dans cette synthèse seront retracés le rôle potentiel des télomères dans la sénescence des cellules somatiques humaines, ainsi que la fonction de la télomérase dans l’immortalisation de ces cellules après l’introduction du gène de la sous-unité catalytique de la télomérase. En conclusion, les perspectives de l’utilisation d’un tel outil en immunothérapie seront évoquées.
Summary
Telomeres are specialized structures at the end of eukaryotic chromosomes that in vertebrates constain hundreds to thousands of tandem repeats of the sequence TTAGGG. In most human somatic cells, telomeres shorten with each cell division, eventually triggering an irreversible arrest of proliferation called cellular senescence. These observations have led to a model in which telomere length reflects the mitotic history of somatic cells. Further support for this hypothesis has come from the discovery of telomerase, a unique reverse transcriptase ribonucleoprotein that has the ability to extend 3’ end of telomeres.
In fibroblasts, senescence is induced by telomere attrition and depends on p53 and pRb pathways triggered by one or a few critically short telomeres. Previous studies have shown that the replicative life span of various primary human cells can be prolonged by transduction of the telomerase reverse transcriptase (hTERT) gene. The hTERT expressing cells proliferate indefinitely, without undergoing any changes associated with transformation to malignancy. Rapid progress has been made towards the goal of using tumor-specific cytolytic CD8+ T lymphocytes for the immunotherapy of cancer. These cells can be expanded in vitro and, in principle, could be used for adoptive immunotherapy. One of the major problems that remains to be solved is the finite life span of normal human T lymphocytes. In an attempt to overcome this barrier three groups have introduced hTERT cDNA into human T lymphocytes and monitored its effect on their life span. In two of these studies, hTERT significantly extended the replicative life span of CD8+ T clones, whereas this was not the case in the third study using bulk T lymphocytes. Possible explanations for these discordant results are that better growth conditions avoided culture-induced stress in the study with clones, or that clones had undergone alterations leading, for example, to the inactivation of the pRb pathway during their derivation.
Parties annexes
Références
- 1. Blackburn EH. Switching and signaling at the telomere. Cell 2001; 106: 661-73.
- 2. Bryan TM, Cech TR. Telomerase and the maintenance of chromosome ends. Curr Opin Cell Biol 1999; 11: 318-24.
- 3. Hayflick L, Moorhead PS. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 1961; 25: 585-621.
- 4. Harley CB, Vaziri H, Counter CM, Allsopp RC. The telomere hypothesis of cellular aging. Exp Gerontol 1992; 27: 375-82.
- 5. Chiu CP, Harley CB. Replicative senescence and cell immortality: the role of telomeres and telomerase. Proc Soc Exp Biol Med 1997; 214: 99-106.
- 6. Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266: 2011-5.
- 7. Holt SE, Shay JW. Role of telomerase in cellular proliferation and cancer. J Cell Physiol 1999; 180: 10-8.
- 8. Jiang XR, Jimenez G, Chang E, et al. Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype. Nat Genet 1999; 21: 111-4.
- 9. Wright WE, Shay JW. Cellular senescence as a tumor-protection mechanism: the essential role of counting. Curr Opin Genet Dev 2001; 11: 98-103.
- 10. Cerottini JC, MacDonald HR. The cellular basis of T-cell memory. Annu Rev Immunol 1989; 7: 77-89.
- 11. Brummendorf TH, Lansdorp PM, Rufer N. Telomere length dynamic in normal and malignant hematopoiesis. J Anti-Aging Med 2000; 3: 395-407.
- 12. Weng NP, Hathcock KS, Hodes RJ. Regulation of telomere length and telomerase in T and B cells: a mechanism for maintaining replicative potential. Immunity 1998; 9: 151-7.
- 13. Rufer N, Brümmendorf TH, Kolvraa S, et al. Telomere fluorescence measurements in granulocytes and T lymphocytes subsets point to a high turnover of hematopoietic stem cells and memory T cells in early childhood. J Exp Med 1999; 2: 157-67.
- 14. Broccoli D, Young JW, de Lange T. Telomerase activity in normal and malignant hematopoietic cells. Proc Natl Acad Sci USA 1995; 92: 9082-6.
- 15. Weng NP. Regulation of telomerase expression in human lymphocytes. Springer Semin Immunopathol 2002; 24: 23-33.
- 16. Maini MK, Soares MV, Zilch CF, Akbar AN, Beverley PC. Virus-induced CD8+ T cell clonal expansion is associated with telomerase up-regulation and telomere length preservation: a mechanism for rescue from replicative senescence. J Immunol 1999; 162: 4521-6.
- 17. Weng NP, Palmer LD, Levine BL, Lane HC, June CH, Hodes RJ. Tales of tails: regulation of telomere length and telomerase activity during lymphocyte development, differentiation, activation, and aging. Immunol Rev 1997; 160: 43-54.
- 18. Effros RB, Pawelec G. Replicative senescence of T cells: does the Hayflick limit lead to immune exhaustion? Immunol Today 1997; 18: 450-4.
- 19. Rufer N, Migliaccio M, Antonchuk J, Humphries RK, Roosnek E, Lansdorp PM. Transfer of the human telomerase reverse transcriptase (TERT) gene into T lymphocytes results in extension of replicative potential. Blood 2001; 98: 597-603.
- 20. Migliaccio M, Amacker M, Just T, et al. Ectopic human telomerase catalytic subunit expression maintains telomere length but is not sufficient for CD8+ T lymphocyte immortalization. J Immunol 2000; 165: 4978-84.
- 21. Hooijberg E, Ruizendaal JJ, Snijders PJF, Kueter EWM, Walboomers JMM, Spits H. Immortalization of human CD8+ T cell clones by ectopic expression of telomerase reverse transcriptase. J Immunol 2000; 165: 4239-45.
- 22. Rosenberg SA. Progress in human tumour immunology and immunotherapy. Nature 2001; 411: 380-4.
- 23. Lansdorp PM, Verwoerd NP, Vanderijke FM, et al. Heterogeneity in telomere length of human chromosomes. Hum Mol Genet 1996; 5: 685-91.